KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Operations (2016 - 2025)

Bausch Health Companies' Cash from Operations history spans 17 years, with the latest figure at 495000000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 17.64% year-over-year to 495000000.0; the TTM value through Dec 2025 reached 1400000000.0, down 12.34%, while the annual FY2025 figure was 1400000000.0, 12.34% down from the prior year.
  • Cash from Operations for Q4 2025 was 495000000.0 at Bausch Health Companies, up from 405000000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 601000000.0 in Q4 2024 and bottomed at 1263000000.0 in Q3 2022.
  • The 5-year median for Cash from Operations is 334500000.0 (2024), against an average of 236350000.0.
  • The largest YoY upside for Cash from Operations was 1879.17% in 2022 against a maximum downside of 323.94% in 2022.
  • A 5-year view of Cash from Operations shows it stood at 24000000.0 in 2021, then soared by 1879.17% to 475000000.0 in 2022, then dropped by 17.89% to 390000000.0 in 2023, then soared by 54.1% to 601000000.0 in 2024, then fell by 17.64% to 495000000.0 in 2025.
  • Per Business Quant, the three most recent readings for BHC's Cash from Operations are 495000000.0 (Q4 2025), 405000000.0 (Q3 2025), and 289000000.0 (Q2 2025).